Healthcare Third-Party Logistics (3PL) Market Size, Share & Trends Report by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Healthcare Third-Party Logistics (3PL) Market Size Analysis

Global Healthcare Third-Party Logistics (3PL) Market Introduction
By Product
1. Introduction
  1. Product By Value
2. Biopharmaceuticals
  1. By Value
3. Pharmaceuticals
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Biosimilars
    1. Biosimilars By Value
  4. Plasma Derived Products
    1. Plasma Derived Products By Value
  5. Others
    1. Others By Value
4. Medical Device
  1. By Value
  2. Class I
    1. Class I By Value
  3. Class II
    1. Class II By Value
  4. Class III
    1. Class III By Value
By Service
1. Introduction
  1. Service By Value
2. Transportation
  1. By Value
  2. Air Freight
    1. Air Freight By Value
  3. Sea Freight
    1. Sea Freight By Value
  4. Overland
    1. Overland By Value
3. Warehousing & Storage
  1. By Value
4. Others
  1. By Value
By Supply Chain
1. Introduction
  1. Supply Chain By Value
2. Cold Chain
  1. By Value
3. Non-Cold Chain Logistics
  1. By Value

North America Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Biopharmaceuticals
  1. By Value
3. Pharmaceuticals
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Biosimilars
    1. Biosimilars By Value
  4. Plasma Derived Products
    1. Plasma Derived Products By Value
  5. Others
    1. Others By Value
4. Medical Device
  1. By Value
  2. Class I
    1. Class I By Value
  3. Class II
    1. Class II By Value
  4. Class III
    1. Class III By Value
By Service
1. Introduction
  1. Service By Value
2. Transportation
  1. By Value
  2. Air Freight
    1. Air Freight By Value
  3. Sea Freight
    1. Sea Freight By Value
  4. Overland
    1. Overland By Value
3. Warehousing & Storage
  1. By Value
4. Others
  1. By Value
By Supply Chain
1. Introduction
  1. Supply Chain By Value
2. Cold Chain
  1. By Value
3. Non-Cold Chain Logistics
  1. By Value
U.S.
1. By Product
  1. Introduction
    1. Product By Value
  2. Biopharmaceuticals
    1. By Value
  3. Pharmaceuticals
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Biosimilars
      1. Biosimilars By Value
    4. Plasma Derived Products
      1. Plasma Derived Products By Value
    5. Others
      1. Others By Value
  4. Medical Device
    1. By Value
    2. Class I
      1. Class I By Value
    3. Class II
      1. Class II By Value
    4. Class III
      1. Class III By Value
2. By Service
  1. Introduction
    1. Service By Value
  2. Transportation
    1. By Value
    2. Air Freight
      1. Air Freight By Value
    3. Sea Freight
      1. Sea Freight By Value
    4. Overland
      1. Overland By Value
  3. Warehousing & Storage
    1. By Value
  4. Others
    1. By Value
3. By Supply Chain
  1. Introduction
    1. Supply Chain By Value
  2. Cold Chain
    1. By Value
  3. Non-Cold Chain Logistics
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Biopharmaceuticals
  1. By Value
3. Pharmaceuticals
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Biosimilars
    1. Biosimilars By Value
  4. Plasma Derived Products
    1. Plasma Derived Products By Value
  5. Others
    1. Others By Value
4. Medical Device
  1. By Value
  2. Class I
    1. Class I By Value
  3. Class II
    1. Class II By Value
  4. Class III
    1. Class III By Value
By Service
1. Introduction
  1. Service By Value
2. Transportation
  1. By Value
  2. Air Freight
    1. Air Freight By Value
  3. Sea Freight
    1. Sea Freight By Value
  4. Overland
    1. Overland By Value
3. Warehousing & Storage
  1. By Value
4. Others
  1. By Value
By Supply Chain
1. Introduction
  1. Supply Chain By Value
2. Cold Chain
  1. By Value
3. Non-Cold Chain Logistics
  1. By Value
U.K.
1. By Product
  1. Introduction
    1. Product By Value
  2. Biopharmaceuticals
    1. By Value
  3. Pharmaceuticals
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Biosimilars
      1. Biosimilars By Value
    4. Plasma Derived Products
      1. Plasma Derived Products By Value
    5. Others
      1. Others By Value
  4. Medical Device
    1. By Value
    2. Class I
      1. Class I By Value
    3. Class II
      1. Class II By Value
    4. Class III
      1. Class III By Value
2. By Service
  1. Introduction
    1. Service By Value
  2. Transportation
    1. By Value
    2. Air Freight
      1. Air Freight By Value
    3. Sea Freight
      1. Sea Freight By Value
    4. Overland
      1. Overland By Value
  3. Warehousing & Storage
    1. By Value
  4. Others
    1. By Value
3. By Supply Chain
  1. Introduction
    1. Supply Chain By Value
  2. Cold Chain
    1. By Value
  3. Non-Cold Chain Logistics
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Biopharmaceuticals
  1. By Value
3. Pharmaceuticals
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Biosimilars
    1. Biosimilars By Value
  4. Plasma Derived Products
    1. Plasma Derived Products By Value
  5. Others
    1. Others By Value
4. Medical Device
  1. By Value
  2. Class I
    1. Class I By Value
  3. Class II
    1. Class II By Value
  4. Class III
    1. Class III By Value
By Service
1. Introduction
  1. Service By Value
2. Transportation
  1. By Value
  2. Air Freight
    1. Air Freight By Value
  3. Sea Freight
    1. Sea Freight By Value
  4. Overland
    1. Overland By Value
3. Warehousing & Storage
  1. By Value
4. Others
  1. By Value
By Supply Chain
1. Introduction
  1. Supply Chain By Value
2. Cold Chain
  1. By Value
3. Non-Cold Chain Logistics
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Biopharmaceuticals
    1. By Value
  3. Pharmaceuticals
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Biosimilars
      1. Biosimilars By Value
    4. Plasma Derived Products
      1. Plasma Derived Products By Value
    5. Others
      1. Others By Value
  4. Medical Device
    1. By Value
    2. Class I
      1. Class I By Value
    3. Class II
      1. Class II By Value
    4. Class III
      1. Class III By Value
2. By Service
  1. Introduction
    1. Service By Value
  2. Transportation
    1. By Value
    2. Air Freight
      1. Air Freight By Value
    3. Sea Freight
      1. Sea Freight By Value
    4. Overland
      1. Overland By Value
  3. Warehousing & Storage
    1. By Value
  4. Others
    1. By Value
3. By Supply Chain
  1. Introduction
    1. Supply Chain By Value
  2. Cold Chain
    1. By Value
  3. Non-Cold Chain Logistics
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Biopharmaceuticals
  1. By Value
3. Pharmaceuticals
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Biosimilars
    1. Biosimilars By Value
  4. Plasma Derived Products
    1. Plasma Derived Products By Value
  5. Others
    1. Others By Value
4. Medical Device
  1. By Value
  2. Class I
    1. Class I By Value
  3. Class II
    1. Class II By Value
  4. Class III
    1. Class III By Value
By Service
1. Introduction
  1. Service By Value
2. Transportation
  1. By Value
  2. Air Freight
    1. Air Freight By Value
  3. Sea Freight
    1. Sea Freight By Value
  4. Overland
    1. Overland By Value
3. Warehousing & Storage
  1. By Value
4. Others
  1. By Value
By Supply Chain
1. Introduction
  1. Supply Chain By Value
2. Cold Chain
  1. By Value
3. Non-Cold Chain Logistics
  1. By Value
UAE
1. By Product
  1. Introduction
    1. Product By Value
  2. Biopharmaceuticals
    1. By Value
  3. Pharmaceuticals
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Biosimilars
      1. Biosimilars By Value
    4. Plasma Derived Products
      1. Plasma Derived Products By Value
    5. Others
      1. Others By Value
  4. Medical Device
    1. By Value
    2. Class I
      1. Class I By Value
    3. Class II
      1. Class II By Value
    4. Class III
      1. Class III By Value
2. By Service
  1. Introduction
    1. Service By Value
  2. Transportation
    1. By Value
    2. Air Freight
      1. Air Freight By Value
    3. Sea Freight
      1. Sea Freight By Value
    4. Overland
      1. Overland By Value
  3. Warehousing & Storage
    1. By Value
  4. Others
    1. By Value
3. By Supply Chain
  1. Introduction
    1. Supply Chain By Value
  2. Cold Chain
    1. By Value
  3. Non-Cold Chain Logistics
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Biopharmaceuticals
  1. By Value
3. Pharmaceuticals
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Biosimilars
    1. Biosimilars By Value
  4. Plasma Derived Products
    1. Plasma Derived Products By Value
  5. Others
    1. Others By Value
4. Medical Device
  1. By Value
  2. Class I
    1. Class I By Value
  3. Class II
    1. Class II By Value
  4. Class III
    1. Class III By Value
By Service
1. Introduction
  1. Service By Value
2. Transportation
  1. By Value
  2. Air Freight
    1. Air Freight By Value
  3. Sea Freight
    1. Sea Freight By Value
  4. Overland
    1. Overland By Value
3. Warehousing & Storage
  1. By Value
4. Others
  1. By Value
By Supply Chain
1. Introduction
  1. Supply Chain By Value
2. Cold Chain
  1. By Value
3. Non-Cold Chain Logistics
  1. By Value
Brazil
1. By Product
  1. Introduction
    1. Product By Value
  2. Biopharmaceuticals
    1. By Value
  3. Pharmaceuticals
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Biosimilars
      1. Biosimilars By Value
    4. Plasma Derived Products
      1. Plasma Derived Products By Value
    5. Others
      1. Others By Value
  4. Medical Device
    1. By Value
    2. Class I
      1. Class I By Value
    3. Class II
      1. Class II By Value
    4. Class III
      1. Class III By Value
2. By Service
  1. Introduction
    1. Service By Value
  2. Transportation
    1. By Value
    2. Air Freight
      1. Air Freight By Value
    3. Sea Freight
      1. Sea Freight By Value
    4. Overland
      1. Overland By Value
  3. Warehousing & Storage
    1. By Value
  4. Others
    1. By Value
3. By Supply Chain
  1. Introduction
    1. Supply Chain By Value
  2. Cold Chain
    1. By Value
  3. Non-Cold Chain Logistics
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Healthcare Third-Party Logistics (3PL) Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Agility Logistics
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Barrett Distribution
Cardinal Health
Cencora
CEVA Logistics
DB Schenker
DHL Group
FedEx
Freight Logistics Solutions
Hellmann Worldwide Logistics
Kerry Logistics Network Ltd.
Kinesis Medical B.V.
KUEHNE + NAGEL
Nippon Express Co., Ltd.
Ryder System, Inc.
SF Express
Sinotrans Limited
United Parcel Service of America, Inc.
XPO Logistics, Inc.
Others

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment